Trial intelligence / Profile preview

Remimazolam plus propofol anesthesia for laparoscopic partial hepatectomy

ChiCTR2300068388Phase 4Not yet recruiting

Sponsor
First Affiliated Hospital
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam and propofol in hepatic neoplasm (3 arms), sponsored by First Affiliated Hospital. Primary endpoints: Recovery time and Ricker sedation-agitation score. Planned start Mar 2023; status: not yet recruiting.

02

Drugs

remimazolampropofol
03

Conditions

hepatic neoplasm

Beyond the preview

Go deeper on ChiCTR2300068388.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300068388.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call